Published in

Taylor and Francis Group, Expert Opinion on Drug Safety, 12(20), p. 1565-1572, 2021

DOI: 10.1080/14740338.2021.1963436

Links

Tools

Export citation

Search in Google Scholar

Patients’ perspectives on a drug safety monitoring system for immune-mediated inflammatory diseases based on patient-reported outcomes

Journal article published in 2021 by Leanne J. Kosse, Gerda Weits, Harald E. Vonkeman ORCID, Sander W. Tas, Frank Hoentjen, Martijn Ba Van Doorn ORCID, Phyllis I. Spuls, Geert R. D’Haens ORCID, Michael T. Nurmohamed ORCID, Eugène P. van Puijenbroek ORCID, Bart Jf Van Den Bemt, Naomi T. Jessurun ORCID
Distributing this paper is prohibited by the publisher
Distributing this paper is prohibited by the publisher

Full text: Unavailable

Red circle
Preprint: archiving forbidden
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO